South Korea Companion Animal Healthcare Market, by End User, 2018-2027
| Label | Anti-Infectives | Antibiotics | Anti-Inflammatories | Others |
|---|---|---|---|---|
| 2018 | 29.07 USD Mn | 21.74 USD Mn | 14.33 USD Mn | 21.32 USD Mn |
| 2019 | 31.05 USD Mn | 23.19 USD Mn | 15.49 USD Mn | 22.9 USD Mn |
| 2020 | 32.82 USD Mn | 24.48 USD Mn | 16.57 USD Mn | 24.35 USD Mn |
| 2021 | 35.26 USD Mn | 26.26 USD Mn | 18 USD Mn | 26.31 USD Mn |
| 2022 | 37.95 USD Mn | 28.21 USD Mn | 19.59 USD Mn | 28.47 USD Mn |
| 2023 | 40.9 USD Mn | 30.36 USD Mn | 21.36 USD Mn | 30.86 USD Mn |
| 2024 | 44.17 USD Mn | 32.74 USD Mn | 23.33 USD Mn | 33.51 USD Mn |
| 2025 | 47.78 USD Mn | 35.36 USD Mn | 25.53 USD Mn | 36.46 USD Mn |
| 2026 | 51.78 USD Mn | 38.26 USD Mn | 27.97 USD Mn | 39.74 USD Mn |
| 2027 | 56.22 USD Mn | 41.48 USD Mn | 30.72 USD Mn | 43.4 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the South Korea Companion Animal Healthcare Market, by Pharmaceuticals, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 158 Mn in 2026 and is projected to reach USD 172 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
- Of the 4 groups compared here, Anti-Infectives is out front by 2027 at 56. 22M USD — 33% of the group total.
- What the regional split looks like (2026): Anti-Infectives leads, holding roughly 33% of segment value — the single largest regional share. Others is the second-largest contributor. Antibiotics and Anti-Inflammatories make up the remainder, in descending order.
- By 2027, Anti-Infectives alone is expected to reach USD 56 Mn, with Others at USD 43 Mn.
Market Dynamics
Of the 4 groups compared here, Anti-Infectives is out front by 2027 at 56.22M USD — 33% of the group total.
Second place: Others, 43.40M USD, trailing Anti-Infectives by 23%.
Anti-Infectives grows to 56.22M USD by 2027, from 29.07M USD in 2018 — 93% up.
Others climbs from 21.32M USD (2018) to 43.40M USD (2027), a 104% gain.
Antibiotics: 21.74M USD to 41.48M USD, 91% higher by 2027.
Anti-Inflammatories: up 114% over the period, 14.33M USD to 30.72M USD.
The fastest mover is Anti-Inflammatories, up 114% over the period — a steeper climb than any of the other 4 groups here.
Combined, all 4 groups add up to 171.82M USD by 2027 — 99% up from 86.46M USD in 2018.
Who Leads, And By How Much
This is a comparison chart, 4 groups at once — the interesting question is usually how the gap between them changes, not the value of any single group in isolation.
Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.
The most practical way to read this is relative: set the South Korea Companion Animal Healthcare market figures beside other regions or segments of the same market to see where growth is concentrated.
This is a market research forecast, not an official statistic. Values after the 2018 base year are modeled projections to 2027, based on supply-side and demand-side analysis, and are updated when market conditions change.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Charts From Same Market
View AllSouth Korea Companion Animal Healthcare Market, by Diagnostics, 2018-2027
South Korea Companion Animal Healthcare Market, by Feed Additives, 2018-2027
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



